A decade of investments in monitoring the HIV epidemic: how far have we come? A descriptive analysis by Tobias Alfven et al.
Alfven et al. Health Research Policy and Systems 2014, 12:62
http://www.health-policy-systems.com/content/12/1/62RESEARCH Open AccessA decade of investments in monitoring the
HIV epidemic: how far have we come? A
descriptive analysis
Tobias Alfven1*, Lotus McDougal2, Luisa Frescura1, Christian Aran1, Paul Amler3 and Wayne Gill4Abstract
Background: The 2001 Declaration of Commitment (DoC) adopted by the General Assembly Special Session on
HIV/AIDS (UNGASS) included a call to monitor national responses to the HIV epidemic. Since the DoC, efforts and
investments have been made globally to strengthen countries’ HIV monitoring and evaluation (M&E) capacity. This
analysis aims to quantify HIV M&E investments, commitments, capacity, and performance during the last decade in
order to assess the success and challenges of national and global HIV M&E systems.
Methods: M&E spending and performance was assessed using data from UNGASS country progress reports. The
National Composite Policy Index (NCPI) was used to measure government commitment, government engagement,
partner/civil society engagement, and data generation, as well as to generate a composite HIV M&E System
Capacity Index (MESCI) score. Analyses were restricted to low and middle income countries (LMICs) who submitted
NCPI reports in 2006, 2008, and 2010 (n =78).
Results: Government commitment to HIV M&E increased considerably between 2006 and 2008 but decreased
between 2008 and 2010. The percentage of total AIDS spending allocated to HIV M&E increased from 1.1% to 1.4%,
between 2007 and 2010, in high-burden LMICs. Partner/civil society engagement and data generation capacity
improved between 2006 and 2010 in the high-burden countries. The HIV MESCI increased from 2006 to 2008 in
high-burden countries (78% to 94%), as well as in other LMICs (70% to 77%), and remained relatively stable in 2010
(91% in high-burden countries, 79% in other LMICs). Among high-burden countries, M&E system performance
increased from 52% in 2006 to 89% in 2010.
Conclusions: The last decade has seen increased commitments and spending on HIV M&E, as well as improved M&E
capacity and more available data on the HIV epidemic in both high-burden and other LMICs. However, challenges
remain in the global M&E of the AIDS epidemic as we approach the 2015 Millennium Development Goal targets.
Keywords: AIDS spending, United Nations General Assembly Special Session on HIV/AIDS (UNGASS), HIV, Monitoring
and evaluation, National Composite Policy IndexBackground
Since the 2001 United Nations General Assembly Special
Session (UNGASS) Declaration of Commitment on HIV/
AIDS [1], countries and the international community
have channeled unprecedented political and financial
support to the fight against AIDS. Investments increased
eight-fold during the 10 years that followed the Declar-
ation to over $16.8 billion in 2011 and $18.9 billion in* Correspondence: alfvent@unaids.org
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unless otherwise stated.2012 [2]. There has been a parallel increase in focus on
accountability to ensure that this funding is spent re-
sponsibly and to enable programmatic improvement,
policy change, and a greater understanding of the evolv-
ing nature of the AIDS epidemic. This is dependent on
high quality, representative data, which is in large part
gathered from national monitoring and evaluation (M&E)
efforts. These data, and the related data systems, are es-
sential to enable countries to have greater ownership of
their response by allowing them to plan for, collect,
analyze, disseminate, and use HIV-related data to inform
the national response [3]. Strengthening national M&ELtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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bating the AIDS epidemic. Country-owned HIV M&E sys-
tems without duplication are supported by the “Three
Ones” principles [4], which sought to create a nationally
unified data system to support the information needs of a
dramatically escalating HIV epidemic.
Creating, maintaining, and improving national health
information systems requires sustained investment of
political, human, and financial resources [5]. General
guidance states that 5% to 10% of the national AIDS
budget should be used for HIV M&E activities [6]. There
has been substantial investment in HIV M&E systems in
the last 10 years [7], as well as several efforts to define
the basic components of a functional HIV M&E system
[3,8]. However, to our knowledge, there has not been a
quantitative assessment of M&E investments and na-
tional HIV M&E system capacity on a global scale.
The goal of this paper is to quantify HIV M&E invest-
ments, commitments, capacity, and performance in the
decade following the Declaration of Commitment to in-
form the current global discussion on expanding access
and use of development data, and ensure increased sup-
port for accountability systems in the context of the
post-2015 agenda.Methods
Data source
Data on M&E spending, systems, and performance were
derived from UNGASS country reports submitted in
2006 [9], 2008 [10], and 2010 [11]. Country Progress Re-
ports, including a core set of indicators, have been sub-
mitted to the Joint United Nations Programme on HIV/
AIDS (UNAIDS) every second year since 2004 as part of
the UNGASS reporting system [11]. Information on gov-
ernment commitment, government engagement, part-
ner/civil society engagement, data generation, and data
dissemination/utilization at the national level was taken
from the National Composite Policy Index (NCPI) question-
naire [11], which is an integral part of the UNGASS process
and the most routinely collected data globally on M&E
system capacity. The NCPI is a two-part questionnaire,Table 1 UNGASS and NCPI reporting response rates, 2006–20
2006 200
N % N
All countries (n =192)
Submitted UNGASS report 143 75% 153
Submitted NCPI report 95 50% 137
Low- and middle-income countries (n =145)
Submitted UNGASS report 116 81% 125
Submitted NCPI report 82 57% 117
1Countries who submitted reports in 2006, 2008, and 2010.the first section of which solicits government feedback on
the HIV/AIDS strategic plan, political support, prevention,
treatment, care and support, and M&E. The second sec-
tion is administered to civil society organizations and bi-
lateral and multilateral agencies, and assesses human
rights, civil society involvement, prevention and treatment,
and care and support. Country response rates over the
2006, 2008, and 2010 reporting cycles ranged from 50% to
90% (Table 1).Sample
These analyses were restricted to low- and middle-income
countries (LMICs) who submitted NCPI questionnaires in
each of the 2006, 2008, and 2010 reporting cycles (n =78)
in order to assess trends over time. The 2004 NCPI report-
ing was excluded as it did not include a M&E section.
The 78 LMICs who submitted NCPI questionnaires in
2006, 2008, and 2010 were subdivided into the 22 LMICs
with the highest number of people living with HIV, here-
after known as the “high-burden countries”, compared
with 56 other LMICs (hereafter known as “other LMICs”).
The high-burden countries are Angola, Botswana, Brazil,
Burundi, Cameroon, Côte d’Ivoire, India, Indonesia, Kenya,
Lesotho, Malawi, Mozambique, Namibia, Nigeria, Russian
Federation, Rwanda, South Africa, Swaziland, Uganda,
Ukraine, Vietnam, and Zambia. The other LMICs are
Algeria, Argentina, Armenia, Bangladesh, Belarus, Belize,
Benin, Bulgaria, Burkina Faso, Cambodia, Chile, Colombia,
Comoros, Congo, Costa Rica, Democratic Republic of the
Congo, Dominica, Ecuador, El Salvador, Ethiopia, Fiji,
Gabon, Georgia, Guatemala, Guinea, Guinea-Bissau, Is-
lamic Republic of Iran, Kyrgyzstan, Lao People’s Demo-
cratic Republic, Madagascar, Malaysia, Mali, Marshall
Islands, Mauritius, Mongolia, Morocco, Nepal, Nicaragua,
Pakistan, Palau, Panama, Paraguay, Philippines, Republic
of Moldova, Romania, Saint Kitts and Nevis, Saint Lucia,
Saint Vincent and the Grenadines, Senegal, Somalia, Sri
Lanka, Tajikistan, the former Yugoslav Republic of
Macedonia, Togo, Turkey, and Uruguay.
This analysis focuses on four primary areas: govern-
ment commitments to HIV M&E systems, HIV M&E10
8 2010 2006–20101
% N % N %
80% 182 95% 129 67%
71% 172 90% 86 45%
86% 141 97% 110 76%
81% 135 93% 78 54%
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system performance.
Government commitments
Government commitment was measured using three
questions in the NCPI, outlined in Additional file 1. The
scores for each question were averaged to create a do-
main score for each country, as explained further below
and detailed in Additional file 1. There were two ques-
tions that could not be included in the domain score as
they were not asked in all three reporting cycles, but are
displayed in Table 2.
HIV M&E expenditures
HIV M&E expenditures were drawn from UNGASS
Indicator 1 which measures levels of HIV/AIDS spend-
ing and is collected through a standard reporting formTable 2 Summary of government commitment to HIV monitori
countries who completed the NCPI questionnaires in 2006, 200
Government commitment
HIV M&E plan High-burden LM
Other LMICs
HIV M&E plan budget High-burden LM
Other LMICs
Secured funding for HIV M&E plan budget High-burden LM
Other LMICs
HIV M&E expenditure monitoring2 High-burden LM
Other LMICs
HIV M&E framework present in national strategic plan2 High-burden LM
Other LMICs
Government commitment score High-burden LM
Other LMICs
Note: Confidence levels above 100% have been capped at 100%.
1Indicates the number of countries with a response for that question.
2Excluded from calculation of domain score as the question was not asked in all th[11]. This national funding matrix is a two-dimensional
matrix showing how funds are spent at the national level
and where those funds are sourced. This is accomplished
by relating financing sources (funding entities that dis-
burse money to agents) with AIDS spending categories
(goods, services, and activities delivered as part of the HIV
response).
Domestic spending can be classified in the National
Funding Matrix under 89 specific spending categories.
The spending categories follow a functional classification
described in the National AIDS Spending classifications
and definitions [12,13]. We analyzed the spending trends
and funding sources of M&E expenditures which are cat-
egorized under AIDS spending category 04.03 “Monitor-
ing and evaluation” [12]. In addition, analyses included a
broader sub-set of spending categories which we con-
sidered important components of an adequate M&Eng and evaluation systems among low- and middle-income
8, and 2010
2006 2008 2010
N1 Score N1 Score N1 Score
ICs 22 64% 22 95% 22 95%
(44–83) (89–100) (86–100)
46 61% 56 83% 55 83%
(50–72) (75–91) (75–91)
ICs 20 78% 22 98% 21 95%
(58–97) (93–100) (85–100)
40 65% 52 75% 39 78%
(51–79) (66–84) (65–91)
ICs 16 69% 20 70% 20 60%
(43–94) (48–92) (36–84)
25 72% 39 69% 28 43%
(53–91) (54–84) (23–62)
ICs – – – – 20 80%
(61–99)
– – – – 25 80%
(63–97)
ICs – – 22 100% 22 91%
(78–100)
– – 55 91% 56 93%
(83–99) (86–100)
ICs 22 65% 22 88% 22 81%
(49–81) (80–96) (70–92)
46 57% 56 72% 55 65%
(47–68) (65–80) (59–72)
ree reporting cycles.
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the following: 04.04 (Operations research), 04.05 (Sero-
logical surveillance), 04.06 (HIV drug-resistance sur-
veillance), 04.08 (Information technology), and 04.09
(Patient tracking) in addition to 04.03 “Monitoring and
evaluation”.
A descriptive analysis of HIV and health expenditures
in the time span from 2007 to 2010 of the subset of 43
LMICs with reported data for at least two of these four
years was conducted. Spending data prior to 2007 was
not available. Comparable data was used to reveal the
trend of the share of M&E and M&E + out of total spend-
ing on HIV/AIDS. When necessary, the quantity of data
points was broadened by conducting a linear interpolation
between two known points in the dataset.HIV M&E system capacity
HIV M&E system capacity was calculated as a composite
of three domains: government engagement, partner/civil
society engagement, and data generation. All NCPI ques-
tions related to M&E from both government and civil so-
ciety sections administered as part of the 2006, 2008, and
2010 UNGASS reporting cycle were reviewed. Questions
that remained consistent over the three cycles and were
relevant to HIV M&E system capacity were grouped into
three domains: government engagement, partner and civil
society engagement, and data generation. Percentage
scores for each question were calculated using the scoring
rubric outlined in Additional file 2.Index construction and analysis
The three domains, (i) government engagement, (ii) part-
ner and civil society engagement, and (iii) data generation,
were also aggregated to form an index score, the HIV
M&E System Capacity Index (MESCI) (see Additional file
2 for individual components and scoring calculations).
While information on data utilization was collected
through the NCPI, only one question was asked in all
three reporting cycles, and is therefore not included in do-
main or index calculations.
To calculate the MESCI, an arithmetic mean was gener-
ated for each of the three domains in the MESCI using the
scoring methodology outlined in Additional file 2. Means
included only questions that were asked in 2006, 2008,
and 2010 NCPI cycles. The three domain scores were then
averaged to generate the overall HIV M&E System Cap-
acity Index, which ranges from 0% to 100%, for each coun-
try and each time-point. MESCI component, domain, and
overall scores, including 95% confidence intervals, are pre-
sented for each round of UNGASS reporting, stratified by
high-burden countries vs. other LMICs. Countries that
did not answer a particular question were given a missing
value for that question, rather than imputing a response.HIV M&E performance
UNGASS indicator reporting from 2006 to 2010 was used
to represent HIV M&E system performance. Reported
UNGASS indicators were analyzed to assess levels of
country reporting for three data streams, namely indica-
tors measured from nationally representative, population-
based surveys (UNGASS indicator numbers 7, 13 15, 16,
17), behavioral surveillance for key populations at higher
risk of HIV, i.e., men who have sex with men, sex workers,
and people who inject drugs (UNGASS indicator numbers
8, 14, 18, 19, 20, 21, 23), and service delivery metrics were
derived from program data (UNGASS indicator numbers
4,5,6,24) (Additional file 3) [9-11]. Countries reporting any
of the indicators in each data stream were counted as
having reported in that particular data stream. The
scores for each of the three streams were averaged to
create an HIV M&E performance score. We also exam-
ined the number of countries able to report program
data on antiretroviral therapy by sex; this metric was
not available in 2008 and is therefore not included in
the performance score calculations.
All analyses were conducted using SAS v. 9.2.
Results
Government commitment to HIV M&E
Levels of government commitment to HIV M&E gener-
ally increased between 2006 and 2008 (Table 2). This
was particularly true for countries reporting having an
HIV M&E plan in place, which significantly increased
from 64% to 95% in high-burden countries, and from
61% to 83% in other LMICs. The percentage of countries
reporting secured funding for a HIV M&E plan budget
was stable between 2006 and 2008, but decreased between
2008 and 2010. The overall government commitment do-
main score in high-burden countries increased consider-
ably between 2006 and 2008, but decreased slightly from
2008 to 2010 (65% to 88% to 81%, respectively).
HIV M&E expenditures
Over time, reporting on HIV M&E expenditure increased
from 2004 until 2009 when the number of countries re-
ported peaked, since slightly fewer countries reported in
2010. The total AIDS spending for the 43 LMICs studied
grew from 2007 to 2010, reaching a total of $3.9 billion
(Table 3). In these same countries, the percentage of that
money that was spent on both M&E and M&E + grew
steadily from 2007 to 2010 (from 1.16% to 1.38%, and
from 1.55% to 1.91%, respectively). The percentage of total
AIDS spending allotted to M&E and M&E + generally in-
creased over time among high-burden LMICs. However,
high-burden LMICs reported a lower percentage of funds
going to M&E + than that seen in other LMICs in all years
analyzed; the same was true for three of four years of
M&E spending (2007, 2008, and 2010).
Table 3 Total AIDS spending and HIV M&E spending as a percent of total AIDS spending for low- and middle-income
countries (n =43), 2007–2010
2007 2008 2009 2010
Total in $1,000 USD Total in $1,000 USD Total in $1,000 USD Total in $1,000 USD
Total AIDS spending
All LMICs 2,671,854 3,447,988 3,486,981 3,905,516
High-burden LMICs 1,841,206 2,423,261 2,464,152 2,775,669
Other LMICs 337,539 426,205.42 410,692.46 469,596
M&E Total in $1,000 USD % Total in $1,000 USD % Total in $1,000 USD % Total in $1,000 USD %
All LMICs 31,126 1.16% 45,547 1.32% 45,143 1.29% 53,952 1.38%
High-burden LMICs 19,627 1.07% 31,442 1.30% 35,578 1.44% 38,993 1.40%
Other LMICs 4,285 1.27% 5,935 1.39% 5,389 1.31% 6,953 1.48%
M&E+ Total in $1,000 USD % Total in $1,000 USD % Total in $1,000 USD % Total in $1,000 USD %
All LMICs 41,413 1.55% 54,409 1.58% 59,811 1.72% 74,738 1.91%
High-burden LMICs 22,051 1.20% 36,168 1.49% 39,052 1.58% 42,889 1.55%
Other LMICs 6,820 2.02% 8,479 1.99% 10,792 2.63% 10,160 2.16%
M&E is AIDS spending category 04.03 “Monitoring and evaluation”.
M&E + is 04.04 (Operations research), 04.05 (Serological surveillance), 04.06 (HIV drug-resistance surveillance), 04.08 (Information technology), and 04.09 (Patient
tracking) in addition to 04.03 (Monitoring and evaluation).
Low- and middle-income countries (n =43): Algeria, Armenia, Belarus, Bolivia, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African
Republic, Chad, Colombia, Congo, Costa Rica, Democratic Republic of the Congo, El Salvador, Fiji, Gabon, Ghana, Haiti, Honduras, Indonesia, Kazakhstan, Kenya,
Kyrgyzstan, Lao People Democratic Republic, Lesotho, Mali, Mauritius, Myanmar, Niger, Nigeria, Peru, Philippines, Republic of Moldova, Tajikistan, Thailand, The former
Yugoslav Republic of Macedonia, Togo, Ukraine, and Vietnam.
High-burden LMICs included in the NCPI analyses (n = 10): Botswana, Brazil, Burundi, Cameroon, Indonesia, Kenya, Lesotho, Nigeria, Ukraine, Vietnam.
Other LMICs included in the NCPI analyses (n = 18): Algeria, Armenia, Belarus, Bulgaria, Burkina Faso, Colombia, Costa Rica, Democratic Republic of the Congo, El
Salvador, Fiji, Gabon, Kyrgyzstan, Mali, Mauritius, Philippines, Tajikistan, the Former Yugoslav Republic of Macedonia, Togo.
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Government engagement
Overall, there were improvements in government en-
gagement from 2006 to 2008 in both high-burden and
other LMICs, though these gains decreased by 2010 in
high-burden countries (Table 4). However, government
engagement was higher over time in high-burden coun-
tries (84% in 2006 and 2010) compared to other LMICs
(56% in 2006 to 70% in 2010), though the gap did lessen
over time. While the presence of a functional national
HIV M&E unit was reported by 98% of all high-burden
countries and 76% of other LMICs in 2010, only slightly
more than 60% of countries in both groups reported that
these groups meet regularly (representing a more than
20% decrease from 2008 in high-burden countries).
Partner and civil society engagement
In high-burden LMICs, there was a significant increase
in overall partner and civil society engagement from
2006 (66%) to 2008 and 2010 (97% and 94%, respect-
ively) (Table 4). The percentage of high-burden coun-
tries reporting mechanisms to ensure major partners
submit M&E data/reports to the national HIV M&E unit
nearly doubled, from 53% in 2006 to 90% in 2010.
Reporting the existence of an HIV M&E plan developed
in consultation with civil society also increased in high-
burden countries from 75% in 2006 to 95% in 2010. Theperceived extent of civil society inclusion (61% in 2010
for high-burden countries) and the alignment of part-
ners’ HIV M&E requirements with national M&E plans
(a key component of the “Three Ones”; 68% in 2010)
were both lower relative to other scores in this domain
for high-burden countries.Data generation
Overall, high-burden countries had very high scores in
the data generation domain, with improvements from
2006 (81%) to 2008 (97%) that were maintained into
2010 (Table 4). Other LMICs did not report as many im-
provements over time, and in fact showed decreases be-
tween 2008 and 2010 in the number of countries
reporting that their national HIV M&E plan included i)
guidelines on tools for data collection (88% to 85%), ii) a
strategy for assessing data quality (71% to 59%), iii) a
data dissemination and use strategy (84% to 79%) and iv)
the presence of a functional national and subnational
HIS (91% to 85% and 80% to 78%, respectively).Data utilization
While no domain score was calculated for data utiliza-
tion, the percentage of countries producing annual HIV
M&E reports increased steadily from 2006 to 2010
across all LMICs (Table 4).
Table 4 Summary of government and partner/civil society engagement to HIV M&E systems, data generation, and data
dissemination/utilization for HIV M&E systems, and the HIV M&E System Capacity Index among low- and middle-income
countries who completed NCPI questionnaires in 2006, 2008, and 2010
2006 2008 2010
N1 Score N1 Score N1 Score
(95% CI) (95% CI) (95% CI)
Government engagement
HIV M&E priorities determined through national systems assessment2 High-burden LMICs – – – – 22 100%
Other LMICs – – – – 53 72%
(59–84)
Functional national HIV M&E unit High-burden LMICs 20 93% 22 95% 22 98%
(81–100) (90–100) (93–100)
Other LMICs 42 69% 56 71% 54 76%
(56–82) (60–81) (66–86)
National HIV M&E Committee or Working Group that meets regularly High-burden LMICs 20 73% 22 82% 22 61%
(53–92) (71–93) (52–71)
Other LMICs 43 59% 56 63% 56 63%
(46–73) (53–74) (52–73)
HIV M&E human capacity plan at national, subnational,
and service delivery levels2
High-burden LMICs – – – – 22 86%
(74–99)
Other LMICs – – – – 53 63%
(53–73)
HIV M&E trainings at national, subnational, and civil society levels High-burden LMICs 20 85% 19 88% 21 95%
(71–99) (75–100) (90–100)
Other LMICs 44 44% 46 61% 41 68%
(31–57) (51–71) (58–79)
Government engagement domain score High-burden LMICs 21 84% 22 89% 22 84%
(75–92) (81–96) (79–89)
Other LMICs 46 56% 56 66% 56 70%
(46–66) (58–73) (58–79)
Partner and civil society engagement
HIV M&E plan endorsed by key partners High-burden LMICs 14 93% 20 100% 21 95%
(77–100) (85–100)
Other LMICs 22 82% 46 91% 39 97%
(64–99) (83–100) (92–100)
Mechanisms to ensure major partners submit M&E data/reports
to national M&E unit
High-burden LMICs 19 53% 21 95% 21 90%
(28–77) (85–100) (77–100)
Other LMICs 34 65% 48 73% 36 83%
(48–82) (60–86) (71–96)
HIV M&E plan developed in consultation with civil society High-burden LMICs 16 75% 20 95% 21 95%
(51–99) (85–100) (85–100)
Other LMICs 31 81% 47 91% 39 92%
(66–95) (83–100) (84–100)
Perceived extent of civil society inclusion2 High-burden LMICs – – – – 22 61%
(53–68)
Other LMICs – – – – 53 52%
(45–58)
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Table 4 Summary of government and partner/civil society engagement to HIV M&E systems, data generation, and data
dissemination/utilization for HIV M&E systems, and the HIV M&E System Capacity Index among low- and middle-income
countries who completed NCPI questionnaires in 2006, 2008, and 2010 (Continued)
HIV M&E requirements of key partners aligned with national M&E plan2 High-burden LMICs – – 19 70% 21 68%
(60–81) (58–79)
Other LMICs – – 46 65% 37 71%
(56–76) (63–79)
Partner and civil society engagement domain score High-burden LMICs 20 66% 21 97% 21 94%
(46–86) (92–100) (88–100)
Other LMICs 36 70% 53 83% 43 91%
(56–84) (75–91) (84–97)
Data generation
HIV M&E plan includes data collection strategy High-burden LMICs 17 88% 22 100% 21 100%
(71–100)
Other LMICs 33 91% 52 96% 39 97%
(81–100) (91–100) (92–100)
HIV M&E plan data collection strategy components2 High-burden LMICs – – 22 98% 21 100%
(93–100)
Other LMICs – – 52 95% 37 96%
(90–100) (92–100)
HIV M&E plan includes well-defined, standardized indicators High-burden LMICs 17 94% 22 100% 21 100%
(82–100)
Other LMICs 34 88% 52 92% 39 92%
(77–100) (85–100) (84–100)
HIV M&E plan includes guidelines on tools for data collection High-burden LMICs 17 82% 22 100% 21 100%
(62–100)
Other LMICs 34 85% 52 88% 39 85%
(73–98) (79–97) (73–96)
HIV M&E plan includes strategy for assessing data quality High-burden LMICs 16 81% 22 86% 21 95%
(60–100) (71–100) (85–100)
Other LMICs 31 77% 51 71% 39 59%
(62–93) (58–84) (43–75)
HIV M&E plan includes data analysis strategy2 High-burden LMICs – – – – 21 95%
(85–100)
Other LMICs – – – – 39 77%
(63–91)
HIV M&E plan includes data dissemination and use strategy High-burden LMICs 17 82% 22 95% 21 95%
(62–100) (86–100) (85–100)
Other LMICs 32 88% 51 84% 38 79%
(75–100) (74–95) (65–93)
Functional national health information system (HIS) High-burden LMICs 20 80% 22 95% 22 95%
(61–99) (86–100) (86–100)
Other LMICs 45 87% 54 91% 53 85%
(76–97) (83–99) (75–95)
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Table 4 Summary of government and partner/civil society engagement to HIV M&E systems, data generation, and data
dissemination/utilization for HIV M&E systems, and the HIV M&E System Capacity Index among low- and middle-income
countries who completed NCPI questionnaires in 2006, 2008, and 2010 (Continued)
Functional subnational HIS High-burden LMICs 20 75% 19 100% 22 95%
(54–96) (86–100)
Other LMICs 42 81% 49 80% 46 78%
(69–93) (68–91) (66–91)
HIV program coverage monitoring2 High-burden LMICs – – 22 94% 22 94%
(88–100) (90–99)
Other LMICs – – 56 90% 56 92%
(85–94) (86–98)
Data generation domain score High-burden LMICs 21 81% 22 97% 22 97%
(67–94) (94–99) (94–100)
Other LMICs 46 86% 56 85% 54 82%
(79–93) (79–91) (75–88)
Data utilization
Extent of data usage (planning and implementation) High-burden LMICs – – 22 65% – –
(58–73)
Other LMICs – – 56 69% – –
(63–75)
Extent of data usage (developing/revising national AIDS strategy) High-burden LMICs – – – – 22 65%
(58–73)
Other LMICs – – – – 56 69%
(63–75)
Extent of data usage (resource allocation) High-burden LMICs – – – – 22 75%
(68–81)
Other LMICs – – – – 54 76%
(70–81)
Extent of data usage (program improvement) High-burden LMICs – – – – 22 73%
(64–82)
Other LMICs – – – – 52 69%
(64–74)
Annual HIV M&E report High-burden LMICs 21 86% 21 90% 22 91%
(69–100) (77–100) (78–100)
Other LMICs 46 74% 56 77% 54 80%
(61–87) (65–88) (69–91)
Data utilization domain score3 Top 30 LMICs – – – – – –
Other LMICs – – – – – –
HIV M&E System Capacity Index
HIV M&E System Capacity Index Score High-burden LMICs 22 78% 22 94% 22 91%
(68–88) (90–97) (89–94)
Other LMICs 46 70% 56 77% 56 79%
(62–78) (71–83) (73–84)
Note: Confidence levels above 100% have been capped at 100%.
1Indicates the number of countries with a response for that question.
2Excluded from calculation of domain score, as question was not asked in all three reporting cycles.
3No domain score calculated, as only one question was asked in all three survey rounds.
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Overall, the index improved between 2006 and 2008,
though this improvement was greater in high-burden
LMICs (a significant shift from 78% to 94%) than in
other LMICs (70% to 77%) (Table 4). High-burden LMICs
saw a slight decrease between 2008 and 2010. Among high
burden LMICs, the trajectories of government commit-
ment and HIV M&E system capacity map closely onto
one another, while in other LMICs, government commit-
ment decreases from 2008–2010 as HIV M&E system cap-
acity increases (Figure 1).
HIV M&E system performance
M&E system performance generally shows improve-
ments over time among all LMICs regardless of HIV
burden (Table 5). For high-burden countries, the overall
progress summary score significantly increased from
52% in 2006 to 89% in 2010 and from 37% to 89% for
other LMICs. In 2006, only half of the high-burden
countries and just one in five of the other LMICs could
report on indicators related to the population based
indicators. By 2010, this had significantly increased to
95% of high-burden and 84% of other LMICs. The
same trend is also seen for indicators related to key
populations, with increases from 23% to 73% for high-
burden countries and from 50% to 82% for other LMICs,
as well as for the service delivery indicators (from 82%
to 100% for high-burden and 41% to 100% for other
LMICs).
Among high burden countries, both MESCI and
HIV M&E performance increase from 2006–2008, and
level or slightly decrease by 2010 (Figure 2). In con-
trast, among other LMICs, HIV M&E performance









Figure 1 Government commitment score and HIV Monitoring and Eva
Solid lines represent high-burden LMICs, dotted lines represent other LMICDiscussion
The rapid expansion of available resources to fight the
global AIDS epidemic since the new millennium has
brought with it commensurate expectations for account-
ability at subnational, national, and international levels.
Our analysis shows that government commitment to
HIV M&E, particularly among high-burden LMICS, has
increased considerably since 2006, as has the percentage
of AIDS spending allocated to HIV M&E. As govern-
ment commitments and spending have increased, so
have government and partner engagement, data use, and
data generation. Over this same time period, HIV M&E
system performance has increased by over 70% in high-
burden LMICs, and by 140% in other LMICs.
Reported HIV M&E expenditures were low across the
board when judged against the 5% to 10% of total AIDS
spending as a recommended benchmark [6], never being
higher than 1.4% in high-burden countries. While it is
likely that there were additional sources of funding for
HIV M&E systems beyond those reported in UNGASS
reporting, it seems unlikely that they would reach rec-
ommended levels. However, the suggested level may also
need to be reconsidered at this time as evidenced by the
improved performance of the M&E systems at current
funding levels.
Many countries still lack the systems to actually track
spending on M&E, a barrier that is not confined to the
AIDS response. Recognizing this challenge, overall sup-
port to national statistical services from international
agencies and donor countries has grown considerably,
from $US1.0 billion in 2006 to $US2.3 billion in 2010–
2012 [14].
The relationship seen between the MESCI score and
HIV M&E systems performance (Figure 2) indicates that
among high-burden LMICs, countries with high capacity08 2010
HIV M&E System Capacity Index score
luation System Capacity Index Score from 2006 to 2010. Note:
s.
Table 5 Monitoring and evaluation system performance 2006–2010, as measured through country-reported UNGASS data
2006 2008 2010
N1 %2 N1 %2 N1 %2
(95% CI) (95% CI) (95% CI)
HIV M&E system performance
Population-based indicator stream High-burden LMICs 11 50% 20 91% 21 95%
(29–71) (79–100) (87–100)
Other LMICs 11 20% 53 95% 47 84%
(3–36) (85–100) (69–99)
Key population indicator stream High-burden LMICs 5 23% 15 68% 16 73%
(5–40) (49–88) (54–91)
Other LMICs 28 50% 45 80% 46 82%
(29–71) (64–97) (66–98)
Service delivery indicator stream High-burden LMICs 18 82% 22 100% 22 100%
(66–98)
Other LMICs 23 41% 56 100% 56 100%
(21–62)
Sex disaggregated data on antiretroviral therapy3 High-burden LMICs 18 82% – – 19 86%
(66–98) (72–100)
Other LMICs 35 63% – – 44 79%
(42–83) (61–96)
HIV M&E performance score High-burden LMICs 11 52% 19 86% 20 89%
(34–69) (73–100) (77–100)
Other LMICs 21 37% 51 92% 50 89%
(17–57) (81–100) (75–100)
Note: Confidence levels above 100% have been capped at 100%.
1Indicates the number of countries with a response for that group of questions.
2Percent of 22 high-burden LMICs/56 other LMICs submitting any data for each indicator stream.








HIV M&E System Capacity Index score HIV M&E performance score
Figure 2 HIV Monitoring and Evaluation System Capacity Index Score and HIV monitoring and evaluation performance score from
2006 to 2010. Note: Solid lines represent high-burden LMICs, dotted lines represent other LMICs.
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national and international needs. This relationship does
not seem to hold true for other LMICs, where system
performance is higher than system capacity. One poten-
tial explanation is that countries with lower burdens of
HIV are able to monitor their epidemic with a lower
system capacity than that required for high-burden
countries.
The mandate for national and international HIV M&E
provided in the 2011 Political Declaration on HIV/AIDS
[15], to further strengthen and support HIV data sys-
tems while working to integrate them with broader na-
tional health systems, is a significant shift from the
previous strategy of often parallel systems. There has
also been a call to use HIV resources more strategically,
to encourage greater efficiencies and higher performance
[16]. The decrease seen in the number of high-burden
countries reporting a National HIV M&E Committee or
Working Group that meets regularly may be of concern,
as that is one of the main bodies that will be able to
guide the integration agenda that has been set for HIV
M&E. However, it may also be the evolution of M&E
systems from the early and intensive development stages
to the current and more established systems mainten-
ance stage. Folding the resources and experience from
the HIV response in with those of other health sectors
offers the opportunity for synergies that could be used
to leverage the maximum benefit out of all systems and
resources. Neither the NCPI M&E section nor the
MESCI as they are currently structured are able to
measure integration between HIV M&E systems and
other national M&E systems, but this is an important
modification that should be considered in future years.
Since the beginning of the AIDS epidemic, civil society
has played a key role in the response in countries all
over the world. The engagement in the monitoring of
the AIDS epidemic has also been shown to be important
[17]. Civil society engagement in the development of
M&E plans was reported to be high already in 2008
(around 80% of countries) and increased to more than
90% of countries in 2010. However, the perceived extent
of civil society inclusion was lower, at only 60% in high-
burden countries and 50% in other LMICs, leaving room
for considerable improvements.
This study has several key limitations. Data on govern-
ment commitments and system capacity is derived from
the NCPI, which is self-reported data representing both
national government representative’s opinions of the sta-
tus and performance of their HIV M&E systems and
civil society/bilateral/multilateral opinion on perceived
inclusion in HIV M&E activities. The nature of response
to some of these questions is therefore dependent to
some extent on the respondent and their personal mea-
sures of performance. Calculations of domain scores andthe MESCI were limited to questions that appeared in
all three reporting cycles analyzed – as NCPI reporting
continues, the contents of each domain may be en-
hanced by a greater breadth of questions asked over
time. Indicator performance and patterns of reporting
over time was used as a proxy for M&E system perform-
ance in countries. Although there are limitations in this
approach, consistent increases in reported data, from
varying sources and data collection systems (program
data, population-based surveys, behavioral surveillance),
indicate that there has been progress in strengthening
national M&E systems in recent years.
The most important reason for conducting M&E is to
provide the data needed for guiding policy and program
implementation. A functional M&E system collates and
presents the data in a way that facilitates data use at all
levels, including the general public and beneficiaries of
HIV services [3]. Countries rated their data utilization
for the development/revising of national AIDS strategies,
resource allocation and program improvement in 2010
above average in most countries, though there is room
for improvement. Accurate and regular data utilization
is critical to ensuring epidemiologically appropriate and
evidence-based resource allocation; gaps in this process
may be in part responsible for the variable resource allo-
cation strategies currently seen across countries [18].
Through the UNGASS reporting mechanism, coun-
tries were asked to submit nationally representative data.
However, for an effective response it is not sufficient to
collect data at the national level but data is also needed
at the subnational level, e.g., to identify geographic areas
where localized HIV epidemics or specific populations
most affected by the epidemic are not being reached by
services. In recent years, more focus has been put on
these efforts [19].
The gathering of reliable data on the AIDS epidemic
and the response to it is of increasing importance for
donors such as the Global Fund to Fight AIDS, Tubercu-
losis, and Malaria, for whom performance-based funding
is a core principle [20]. M&E is a cornerstone of this ap-
proach and allows donors to make funding decisions
against proven measurable results. More recently, the
Global Fund to Fight AIDS, Tuberculosis, and Malaria’s
New Funding Model has put greater emphasis on impact
measurement and allocative efficiency [21]. Further ex-
amples include the Investment Framework at a national
level [16] and the PEPFAR reporting requirements at a
donor level [22].
Conclusions
This analysis demonstrates increases in all domains of
HIV M&E systems assessed between 2006 and 2010, as
well as in HIV M&E funding, though the latter remained
well below the recommended benchmarks. In this same
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stantially. Building national M&E systems requires sus-
tained efforts over long periods of time with effective
leadership and coordination [7]. Ongoing investments
into effective HIV M&E systems and data utilization are
required. However, with the increased resource con-
straints in many countries, these investments must be
spent strategically and according to the specific needs of
each country [16]. There is no single M&E system that
fits all countries; the systems should be based on an effi-
cient and effective mix of standardized methods of data
collection and analyses that meet country and inter-
national needs [23]. The 2011 Political Declaration on
HIV/AIDS calls for the integration of HIV M&E systems
into broader health information systems, a major reposi-
tioning for many countries who have invested heavily in
parallel M&E systems [4]. This alignment of vertical in-
terventions with the broader health system has gained
momentum in light of the health-related Millennium
Development Goal targets for which effective scale-up of
services for individual diseases relies on the strength of
the health system as a whole. In June 2013, a report
published by the High-Level Panel on the Post 2015
Development Agenda called for a “New Data Revolu-
tion” to strengthen existing data collection systems in
order to provide timely data for decision making, monitor
delivery gaps, and ensure greater accountability [6]. The
mandate to integrate HIV M&E systems within broader
health information systems provides new opportunities to
leverage and strengthen existing infrastructures. Analyses
such as this offer key insights into this process, and should
be a routine component of M&E system evaluation.Additional files
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